Zyden Gentec (Delisted) financials and balance sheet

BSE: 530091Pharmaceuticals & Biotechnology

Last traded ₹0.87 on 28 Mar 2016

Delisted on 23 Nov 2023.

7 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Zyden Gentec annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
Peak revenue ₹9.70 Cr, year to Mar 2008A loss in 3 of the 7 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2014

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue1.8
  2. Operating expenses−2.1
  3. Operating profit−0.3
  4. Depreciation−0.4
  5. Other income−0.2
  6. Finance costs−0.1
  7. Profit before tax−1.1
  8. Net profit−1.1

Profit and loss

Standalone, ₹ crore, years to March.Zyden Gentec quarterly results

₹ croreMar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014
Revenue from operations9.7–––9.57.51.8
8.5–––12.58.62.1
Materials and goods bought7.022.114.412.59.96.6–
Employee costs––––1.00.8–
Other expenses––––1.61.2–
Operating profit before depreciation1.2–––−2.9−1.0−0.3
Operating margin12.5%–––−31.0%−13.5%−16.2%
Materials, % of revenue––––104.3%87.6%–
Employee costs, % of revenue––––10.4%10.1%–
Other expenses, % of revenue––––16.3%15.8%–
Depreciation and amortisation0.10.10.20.30.40.30.4
Operating profit after depreciation1.1–––−3.4−1.3−0.7
Other income–0.0––0.10.9−0.2
Finance costs0.10.20.40.81.20.40.1
One-off items−0.5––––––
Profit before tax0.41.10.70.0−4.5−0.7−1.1
0.10.10.1–−0.4––
Net profit0.30.00.10.0−4.1−0.7−1.1
Net margin3.4%–––−43.1%−9.7%−58.4%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the years to Mar 2008 and Mar 2014 they do not, so they are left blank. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2009, Mar 2010 and Mar 2011: the statement does not state its revenue or total expenses, which operating profit is worked out from, so operating profit is not given.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014
––––––
As stated that year₹0.04₹0.02₹0.09−₹0.37−₹0.07−₹0.96
––––––
Market cap at the year end (₹ crore)–9.48.210.138.915.1
Every year is restated for later splits and bonuses, so they do not break the line. The figure the company stated that year is under each line it differs from.

Ratios

Standalone, years to March.

RatioMar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014
Revenue growth–––––−20.6%−75.8%
Net profit growth–−93.6%452.4%−62.1%–––
Interest cover14.6––––––
Interest cover is left blank for the years to Mar 2012, Mar 2013 and Mar 2014: operating profit after depreciation is a loss, and a loss covers no interest bill.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2014.

Measure3 years
Operating margin, average−20.2%
Net margin, average−37.0%

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014
Effective tax ratePublished threshold 17.16 per cent23.118.5812.61––––
A threshold marked as ours has no published figure; it is the line we read the check against.